Skip to main navigation
Home

Main navigation

  • Patients
    • For Patients
    • About HCM
    • About DCM
    • Clinical Trials
    • Access Policy
  • Science
    • Our Scientific Approach
    • Publications & Presentations
  • Programs
    • Our Pipeline
    • Mavacamten
    • MYK-224
    • LUS-1
    • MYK-491
    • ACT-1
  • Researchers
    • For Researchers
    • Grants & Funding
  • Investors
    • Press Releases
    • Events & Presentations
    • FAQ
  • Careers
    • Become a Myokardian
    • Current Opportunities
  • About
    • About Myokardia
    • Our Leadership
    • Our History
    • Life at MyoKardia
    • Contact Us
Menu

Investors & Media

Menu

  • Press Releases
  • Events & Presentations
  • Analyst Coverage
  • Investor FAQ
  • Online Investor Kit

Event Details

MyoKardia Conference Call to Discuss Danicamtiv Phase 2a Study

June 22, 2020 at 8:30 AM EDT

Click here for webcast

Supporting Materials

Danicamtiv (MYK 491) A Novel Small Molecule Cardiac Activator: in vitro/in vivo Evidence for Overall Myocardial Inotropy
Phase 2a Study of Danicamtiv (MYK 491) in Patients with Chronic Heart Failure with Reduced Ejection Fraction ( HFrEF )
  • SHAREHOLDER TOOLS
  • PRINT PAGE
  • E-MAIL ALERTS
  • SHARE
  • IR CONTACT
  • RSS FEEDS

  • Facebook
  • Google
  • LinkedIn
  • Twitter
Our core values
  • Patients First
  • Passion for Science
  • Succeed Together
  • Imagine and Innovate
  • Lifelong Learning
  • twitter icon
  • linked in icon
  • Contact
  • Terms of Use
  • Privacy Policy
© 2021 MyoKardia, A Bristol-Myers Squibb Company
              All rights reserved.

Main navigation

  • Patients
    • For Patients
    • About HCM
    • About DCM
    • Clinical Trials
    • Access Policy
  • Science
    • Our Scientific Approach
    • Publications & Presentations
  • Programs
    • Our Pipeline
    • Mavacamten
    • MYK-224
    • LUS-1
    • MYK-491
    • ACT-1
  • Researchers
    • For Researchers
    • Grants & Funding
  • Investors
    • Press Releases
    • Events & Presentations
    • FAQ
  • Careers
    • Become a Myokardian
    • Current Opportunities
  • About
    • About Myokardia
    • Our Leadership
    • Our History
    • Life at MyoKardia
    • Contact Us